Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
MeSH Number(s)
C04.697.655
C23.550.727.655
Concept/Terms
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in Harvard Catalyst Profiles by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 20 | 24 | 44 |
1995 | 16 | 28 | 44 |
1996 | 21 | 50 | 71 |
1997 | 10 | 43 | 53 |
1998 | 15 | 39 | 54 |
1999 | 24 | 37 | 61 |
2000 | 21 | 54 | 75 |
2001 | 24 | 32 | 56 |
2002 | 23 | 38 | 61 |
2003 | 36 | 39 | 75 |
2004 | 40 | 36 | 76 |
2005 | 44 | 45 | 89 |
2006 | 44 | 51 | 95 |
2007 | 54 | 70 | 124 |
2008 | 65 | 62 | 127 |
2009 | 52 | 58 | 110 |
2010 | 77 | 64 | 141 |
2011 | 90 | 78 | 168 |
2012 | 111 | 65 | 176 |
2013 | 145 | 95 | 240 |
2014 | 137 | 59 | 196 |
2015 | 116 | 94 | 210 |
2016 | 116 | 83 | 199 |
2017 | 128 | 97 | 225 |
2018 | 142 | 94 | 236 |
2019 | 139 | 132 | 271 |
2020 | 132 | 169 | 301 |
2021 | 87 | 214 | 301 |
2022 | 23 | 249 | 272 |
2023 | 12 | 234 | 246 |
2024 | 1 | 24 | 25 |
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions. J Urol. 2024 Apr; 211(4):526-532.
-
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy. J Urol. 2024 Apr; 211(4):509-517.
-
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy. J Urol. 2024 Apr; 211(4):518-525.
-
The importance of considering competing risks in recurrence analysis of intracranial meningioma. J Neurooncol. 2024 Feb; 166(3):503-511.
-
Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization. Eur J Surg Oncol. 2024 Mar; 50(3):108012.
-
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5). Blood. 2024 Feb 08; 143(6):496-506.
-
Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults. Cochrane Database Syst Rev. 2024 02 06; 2:CD013561.
-
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001. Blood. 2024 Feb 01; 143(5):404-416.
-
ASO Visual Abstract: Racial and Ethnic Disparities in Outcomes after Breast-Conserving Therapy and Endocrine Therapy for DCIS-A Post Hoc Analysis of the NSABP B-35 Randomized, Clinical Trial. Ann Surg Oncol. 2024 02; 31(2):1010-1011.
-
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology. Acta Neuropathol. 2024 Jan 24; 147(1):23.